Beta-adrenergic antagonist

This page covers all Beta-adrenergic antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Beta-1 and beta-2 adrenergic receptors, Beta-adrenergic receptors (non-selective).

Targets

Beta-1 and beta-2 adrenergic receptors · Beta-adrenergic receptors (non-selective)

Marketed (4)

• Topical timolol maleate · Unity Health Toronto · Ophthalmology
  Topical timolol maleate is a non-selective beta-adrenergic receptor antagonist that reduces intraocular pressure by decreasing aqueous humor production in the eye.
• Timolol 0.5% Ophthalmic Solution · University of California, Davis · Ophthalmology
  Timolol is a non-selective beta-adrenergic receptor antagonist that reduces intraocular pressure by decreasing aqueous humor production in the eye.
• intralesional propranolol injection · Ain Shams University · Dermatology / Oncology
  Intralesional propranolol injection blocks beta-adrenergic receptors within hemangioma tissue, reducing angiogenesis and promoting vascular regression.
• betablocker titration · Policlinico Casilino ASL RMB · Cardiovascular
  Beta-blockers inhibit the effects of catecholamines on beta-adrenergic receptors, reducing heart rate, contractility, and blood pressure.